NSEResignation1d ago · 31 Oct 2026, 02:32 pm
Resignation
Fortis Healthcare Limited · FORTIS
✦ AI SummaryMgmt Change
Fortis Healthcare Limited has informed the Exchange regarding the resignation of Dr. Ritu Garg as Chief Growth & Innovation Officer, effective October 31, 2026, due to other commitments and responsibilities.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fortis Healthcare Limited has informed the Exchange regarding Resignation of Dr. Ritu Garg as Other of the company w.e.f. October 31, 2026.
Attachments (1)
📄pdf
Download →
FORTIS_31102026143202_finalfinal.pdf
View document text
» Fortis Healthcare Limited
** Fo'fis Tower-A, Unitech Business Park, Block-F,
South City 1, Sector — 41, Gurgaon,
Haryana — 122 001 (India)
Tel 10124 492 1033
Fax 10124 492 1041
Emergency : 105010
Email : secretarial@fortishealthcare.com
Website : www.fortishealthcare.com
October 31, 2026
FHL/SEC/2026-27
The National Stock Exchange of India Ltd. BSE Limited
Scrip Symbol: FORTIS Scrip Code:532843
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure
Requirements) Regulations 2015 (SEBI Listing Regulations) - Intimation on resignation
ofa Senior Management Personnel
Dear Madam / Sir,
Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("Listing Regulations") read with SEBI Master Circular dated January 30,
2026, we would like to inform you that Dr. Ritu Garg, Chief Growth & Innovation Officer of
the Company, one of the Senior Management Personnel (“SMP”) of the Company has
tendered her resignation with effect from October 31, 2026 (from close of business hours)
due to other commitments and responsibilities
The detailed disclosure as required under Regulation 30 of the Listing Regulations read with
SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30,
2026 is enclosed as Annexure-A.
Further, the copy of her resignation letter is also enclosed as Annexure- B.
The aforesaid intimation shall be made available on the Company’s website at
www.fortishealthcare.com
This is for your information and record.
Thanking you,
Yours Sincerely,
For Fortis Healthcare Limited
Satyendra Chauhan
Company Secretary & Compliance Officer
M. No. — A14783
Encl.: as above
FORTIS HEALTHCARE LIMITED
Regd. Office : Fortis Hospital, Sector 62, Phase — VI, Mohali - 160062
Tel : 01724692222, Fax: 0172-5096221, CIN : L85110PB1996PLC045933
$2 Fortis
Fortis Healthcare Limited
Tower-A, Unitech Business Park, Block-F,
South City 1, Sector — 41, Gurgaon,
Haryana — 122 001 (India)
Tel 10124 492 1033
Fax 10124 492 1041
Emergency : 105010
Email : secretarial@fortishealthcare.com
Website : www.fortishealthcare.com
Annexure A
Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations. 2015
Particulars Description
Reason for change viz. appeintment, DDr. Ritu Garg, Chief Growth & Innovation Officer of]
re-appointment.—resignation, removaly the Company, one of the Senior Managemen
deatrorothorwises [Personnel (“SMP”) of the Company has tendered her
resignation with effect from October 31, 2026 (from|
close of business hours) due to other commitments and|
responsibilities.
Date of appeintment—re- ith effect from October 31, 2026 (from close of
appointment/ cessation (as [business hours).
applicable) & term of appointment.
Brief profile (in case of NA
appointment).
Disclosure of relationships betweenNA
directors (in case of appointment of
director).
FORTIS HEALTHCARE LIMITED
Regd. Office : Fortis Hospital, Sector 62, Phase — VI, Mohali - 160062
Tel : 01724692222, Fax: 0172-5096221, CIN : L85110PB1996PLC045933
October 31, 2026
Fortis Healthcare Limited
Fortis Hospital, Sector 62, Phase-VIII,
Mohali - 160062, Punjab
Sub: Resignation from the position of Chief Growth & Innovation Officer of the Company
1 hereby tender my resignation from the position of Chief Growth & Innovation Officer of the
Company, with effect from the closure of business hours on Saturday, October 31, 2026 in order
to pursue a professional opportunity outside the organization.
[ take this opportunity to convey my gratitude to the Board of Directors and Management team of
the Company for co-operation, trust and support extended to me throughout during my tenure.
I wish the Company every success with its future plans and ambitions.
Thanking you
Yours Truly
Dr. Ritu Garg
Chief Growth & Innovation Officer
Address- D 8, Surbhi Apartment, Sector 43, Next to Gold Souk, Gurgaon